vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Goosehead Insurance, Inc. (GSHD). Click either name above to swap in a different company.
Goosehead Insurance, Inc. is the larger business by last-quarter revenue ($93.1M vs $62.1M, roughly 1.5× Cytek Biosciences, Inc.). Goosehead Insurance, Inc. runs the higher net margin — 8.6% vs -70.9%, a 79.6% gap on every dollar of revenue. On growth, Goosehead Insurance, Inc. posted the faster year-over-year revenue change (23.1% vs 8.1%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 9.2%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Goosehead Insurance is a U.S.-based personal lines insurance agency that offers a wide range of coverage products including auto, home, renters, flood, and specialty insurance. It partners with hundreds of insurance carriers to provide clients with tailored, cost-effective coverage options, operating via corporate locations and a national franchise network for independent agents.
CTKB vs GSHD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $93.1M |
| Net Profit | $-44.1M | $8.0M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 16.1% |
| Net Margin | -70.9% | 8.6% |
| Revenue YoY | 8.1% | 23.1% |
| Net Profit YoY | -557.1% | 204.0% |
| EPS (diluted) | — | $0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $93.1M | ||
| Q4 25 | $62.1M | $105.3M | ||
| Q3 25 | $52.3M | $90.4M | ||
| Q2 25 | $45.6M | $94.0M | ||
| Q1 25 | $41.5M | $75.6M | ||
| Q4 24 | $57.5M | $93.9M | ||
| Q3 24 | $51.5M | $78.0M | ||
| Q2 24 | $46.6M | $78.1M |
| Q1 26 | — | $8.0M | ||
| Q4 25 | $-44.1M | $12.4M | ||
| Q3 25 | $-5.5M | $7.9M | ||
| Q2 25 | $-5.6M | $5.2M | ||
| Q1 25 | $-11.4M | $2.3M | ||
| Q4 24 | $9.6M | $14.9M | ||
| Q3 24 | $941.0K | $7.6M | ||
| Q2 24 | $-10.4M | $6.2M |
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | — | 16.1% | ||
| Q4 25 | -9.0% | 29.4% | ||
| Q3 25 | -17.6% | 23.5% | ||
| Q2 25 | -23.3% | 16.7% | ||
| Q1 25 | -36.1% | 8.8% | ||
| Q4 24 | 5.2% | 29.7% | ||
| Q3 24 | -8.2% | 21.1% | ||
| Q2 24 | -18.3% | 19.7% |
| Q1 26 | — | 8.6% | ||
| Q4 25 | -70.9% | 11.8% | ||
| Q3 25 | -10.5% | 8.7% | ||
| Q2 25 | -12.2% | 5.5% | ||
| Q1 25 | -27.5% | 3.1% | ||
| Q4 24 | 16.8% | 15.8% | ||
| Q3 24 | 1.8% | 9.7% | ||
| Q2 24 | -22.4% | 7.9% |
| Q1 26 | — | $0.19 | ||
| Q4 25 | — | $0.48 | ||
| Q3 25 | — | $0.29 | ||
| Q2 25 | — | $0.18 | ||
| Q1 25 | — | $0.09 | ||
| Q4 24 | — | $0.58 | ||
| Q3 24 | — | $0.29 | ||
| Q2 24 | — | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $25.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $-121.3M |
| Total Assets | $461.5M | $392.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $25.7M | ||
| Q4 25 | $90.9M | $34.4M | ||
| Q3 25 | $93.3M | $51.6M | ||
| Q2 25 | $75.5M | $92.4M | ||
| Q1 25 | $95.3M | $70.2M | ||
| Q4 24 | $98.7M | $54.3M | ||
| Q3 24 | $162.3M | $47.5M | ||
| Q2 24 | $177.9M | $23.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $289.5M | ||
| Q3 25 | — | $290.0M | ||
| Q2 25 | — | $289.8M | ||
| Q1 25 | — | $290.3M | ||
| Q4 24 | — | $82.3M | ||
| Q3 24 | — | $84.6M | ||
| Q2 24 | — | $87.0M |
| Q1 26 | — | $-121.3M | ||
| Q4 25 | $341.7M | $-95.5M | ||
| Q3 25 | $378.6M | $-105.0M | ||
| Q2 25 | $377.6M | $-78.6M | ||
| Q1 25 | $379.6M | $-88.5M | ||
| Q4 24 | $395.7M | $43.9M | ||
| Q3 24 | $385.5M | $58.3M | ||
| Q2 24 | $389.1M | $39.8M |
| Q1 26 | — | $392.8M | ||
| Q4 25 | $461.5M | $414.9M | ||
| Q3 25 | $494.9M | $403.6M | ||
| Q2 25 | $493.3M | $436.6M | ||
| Q1 25 | $482.6M | $412.6M | ||
| Q4 24 | $499.5M | $397.7M | ||
| Q3 24 | $491.2M | $358.1M | ||
| Q2 24 | $483.7M | $338.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.87× | ||
| Q3 24 | — | 1.45× | ||
| Q2 24 | — | 2.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $91.8M | ||
| Q3 25 | $-3.9M | $24.2M | ||
| Q2 25 | $108.0K | $28.9M | ||
| Q1 25 | $-125.0K | $15.5M | ||
| Q4 24 | $2.0M | $71.5M | ||
| Q3 24 | $13.2M | $28.1M | ||
| Q2 24 | $6.2M | $18.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $86.1M | ||
| Q3 25 | $-4.6M | $23.7M | ||
| Q2 25 | $-1.5M | $27.2M | ||
| Q1 25 | $-974.0K | $14.9M | ||
| Q4 24 | $1.1M | $70.6M | ||
| Q3 24 | $12.2M | $28.0M | ||
| Q2 24 | $5.2M | $18.6M |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 81.8% | ||
| Q3 25 | -8.7% | 26.2% | ||
| Q2 25 | -3.2% | 28.9% | ||
| Q1 25 | -2.3% | 19.7% | ||
| Q4 24 | 1.9% | 75.1% | ||
| Q3 24 | 23.7% | 35.9% | ||
| Q2 24 | 11.0% | 23.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 5.4% | ||
| Q3 25 | 1.3% | 0.5% | ||
| Q2 25 | 3.5% | 1.8% | ||
| Q1 25 | 2.0% | 0.8% | ||
| Q4 24 | 1.6% | 1.0% | ||
| Q3 24 | 2.0% | 0.1% | ||
| Q2 24 | 2.3% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 7.38× | ||
| Q3 25 | — | 3.06× | ||
| Q2 25 | — | 5.61× | ||
| Q1 25 | — | 6.61× | ||
| Q4 24 | 0.21× | 4.82× | ||
| Q3 24 | 14.05× | 3.72× | ||
| Q2 24 | — | 3.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
GSHD
| Renewal Royalty Fees (2) | $43.6M | 47% |
| Renewal Commissions (1) | $18.2M | 20% |
| Contingent Commissions (1) | $10.7M | 11% |
| New Business Royalty Fees (2) | $7.9M | 8% |
| New Business Commissions (1) | $7.5M | 8% |
| Other | $3.7M | 4% |
| Initial Franchise Fees (2) | $1.6M | 2% |
